Tag: manufacturing
Cambrex looks to fill ‘onshore’ API manufacturing demand with $50M expansion...
With the COVID-19 pandemic nearing its second year in the U.S., lawmakers have banged the drum on boosting "onshore" production of key pharmaceuticals and ingredients...
Lonza plots $93M expansion to capsule manufacturing, adding billions of doses...
When CDMO Lonza shelled out $5.5 billion for capsule-maker Capsugel in 2017, it made a big bet the booming capsule market would drive revenue....
Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024,...
After years of manufacturing woes, Pfizer appeared to turn a corner earlier this year for its growing sterile injectables portfolio. But even with signs trending...
Israel’s Mapi Pharma sets aside manufacturing space to boost country’s COVID-19...
With the end of the year fast approaching, nations are looking for ways to secure enough supply of a potential COVID-19 vaccine to meet...
Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost...
Among the contract manufacturers enjoined in the race for a COVID-19 vaccine, Oxford Biomedica has forged a close relationship with AstraZeneca given its choice...
Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine
French drugmaker Valneva hasn't captured the global attention of some of its larger counterparts in the race for a COVID-19 vaccine, but a recent...
Australian CDMO Luina Bio plots biologics manufacturing upgrades big and small
Australian contract research and manufacturing organization Luina Bio is teeing up multiple projects to grow its biologics capacity. Five new site expansions are expected to open by...
Roche, Regeneron join forces to more than triple manufacturing of COVID-19...
Despite hundreds of potential therapies for COVID-19 looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-antibody...
House Dems launch probe into Kodak’s unexpected $765M drug manufacturing loan...
The Trump administration’s surprising $765 million deal that would enable former photography giant Kodak to start making drug ingredients has yet to be finalized,...
Niche vaccine player Valneva, UK tie up in coronavirus R&D and...
COVID-19 frontrunners have been inking deals with governments and others to supply vaccines if their programs succeed, and now niche player Valneva is getting involved.
Valneva on Monday...
